Nipocalimab — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-06-26 in 4d
ESTIMATED |
READOUT
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized
Phase 2/3 · Myasthenia Gravis |
Janssen Research & Development, LL | Nipocalimab |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|